Novocure Denmark ApS: Financial statements 2022
CVR: 43071076
Source: annual report 2022, Danish Business Authority
15/02/2022 – 31/12/2022
Novocure Denmark ApS (CVR 43071076) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,889,508 and a net result of DKK 106,272. Equity in the 2022 report amounted to DKK 146,272. The solvency ratio was 5.3%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 1,889,508
- Profit/Loss
- DKK 106,272
- Equity
- DKK 146,272
- Total Assets
- DKK 2,773,416
- Employees
- 3
Official annual report
Keep an eye on Novocure Denmark ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of February 15, 2022, Ashley Carpenter Cordova is registered as director of Novocure Denmark ApS.
As of February 15, 2022, is registered as an owner of Novocure Denmark ApS with an ownership share of 100%.
Novocure Denmark ApS was founded on February 15, 2022.
About Novocure Denmark ApS
Novocure Denmark ApS is a Danish company of the type Anpartsselskab based in Viby J, founded in 2022. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Marco Adriano Carrino. The company is owned by Novocure GmbH. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 1,313,877 and a net result of DKK 52,751 compared with DKK 833,715 the year before. Equity in the 2025 report amounted to DKK 1,465,999.